Ryan Craig, MD, PhD
Assistant Professor
Education & Affiliations
Biography
Appointment and Position
2020-present Module Co-Director for Phase I Fundamentals of Human Biology (Tulane School of Medicine)
2020-present Module Co-Director for Phase II Mechanisms of Disease (Tulane School of Medicine)
2020-present Pathology Clerkship Director/Pathology Career Advisor for Medical Students
2019-present Assistant Program Director for AP/CP Pathology Residency
2019-present Assistant Medical Director of Clinical Chemistry
2019-present Assistant Professor of Pathology, Tulane University School of Medicine
Publications
Pincus, S.; Craig, R.; Weachter, L.; LaBranche, C.; Nabi, R.; Watt, C.; Raymond, M.; Peters, T.; Song, K.; Maresh, G.; Montefiori, D.; Kozlowski, P. Bispecific Anti-HIV Immunoadhesins That Bind gp120 and gp41 Have Broad and Potent HIV-Neutralizing Activity. Vaccines 2021, 9(7), 774.
Ibrahim M, Chen R, Vegel A, Panse K, Bhyravabhotla K, Harris K, Craig R, Safah H, Saba NS, Socola F. 2021. Treatment of myeloid sarcoma without bone marrow involvement with gemtuzumab ozogamicin-containing regimen. Leuk Res. 2021 April 22;106:106583
Craig RB, Summa CM, Corti M, Pincus SH. 2012. Anti-HIV double variable domain immunoglobulins binding both gp41 and gp120 for targeted delivery of immunoconjugates. PLoS One, 2012;7(10):e46778
Craig R, Cutrera J, Zhu S, Xia X, Lee YH, Li S. 2008. Administering plasmid DNA encoding tumor vessel-anchored IFN-alpha for localizing gene product within on into tumors. Molecular Therapy, 2008 May;16(5):901-6.
Craig R, Li S. 2006. Function and molecular mechanisms of tumor-targeted peptides for delivering therapeutic genes and chemical drugs. Mini Reviews in Medicinal Chemistry, 2006 Jul;6(7):757-64.